It’s an under-appreciated ingredient,” says Melanie Palm, MD, a board-certified dermatologist and cosmetic surgeon at Art of ...

The FDA has approved a subcutaneous induction regimen of guselkumab for the treatment of adults with moderately to severely ...

In TODAY.com's Expert Tip of the Day, a dietitian shares this easy strategy for choosing a snack that won't spike your blood ...

The FDA has approved Keytruda Qlex, a faster, under-the-skin cancer treatment offering convenience and flexibility. Here's what we know.

Tremfya is now the first and only fully subcutaneous IL-23 inhibitor approved to treat both ulcerative colitis and Crohn’s ...

With a fresh endorsement from the FDA, Johnson & Johnson has rounded out Tremfya’s presence in inflammatory bowel disease ...

Tralokinumab self-administered by patients with atopic dermatitis via a pre-filled pen is a safe and effective treatment option.

The platform enables clinicians to tailor GLP-1 titration at scale, aiming to reduce discontinuation rates and improve ...